RB, H., AS, T., MWD, S., IM, N., S, K., NK, A., . . . IM, S. (2026). Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis. Journal for immunotherapy of cancer, 14(3), . https://doi.org/10.1136/jitc-2025-013861
Chicago Style (17th ed.) CitationRB, Holmstroem, et al. "Prospective Study of Patients with Immune Checkpoint Inhibitor-induced Hepatitis; Characterization of Liver Injury, Outcome of Therapy, and Management of Steroid-unresponsive and Steroid-dependent Hepatitis." Journal for Immunotherapy of Cancer 14, no. 3 (2026). https://doi.org/10.1136/jitc-2025-013861.
MLA (9th ed.) CitationRB, Holmstroem, et al. "Prospective Study of Patients with Immune Checkpoint Inhibitor-induced Hepatitis; Characterization of Liver Injury, Outcome of Therapy, and Management of Steroid-unresponsive and Steroid-dependent Hepatitis." Journal for Immunotherapy of Cancer, vol. 14, no. 3, 2026, https://doi.org/10.1136/jitc-2025-013861.
